G. Tezcan Et Al. , "Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed Cancer Cells," INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , vol.23, no.16, 2022
Tezcan, G. Et Al. 2022. Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed Cancer Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , vol.23, no.16 .
Tezcan, G., Alsaadi, M., Hamza, S., Garanina, E. E., Martynova, E. V., Ziganshina, G. R., ... Farukshina, E. R.(2022). Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed Cancer Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , vol.23, no.16.
Tezcan, GÜLÇİN Et Al. "Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed Cancer Cells," INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , vol.23, no.16, 2022
Tezcan, GÜLÇİN Et Al. "Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed Cancer Cells." INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , vol.23, no.16, 2022
Tezcan, G. Et Al. (2022) . "Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed Cancer Cells." INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , vol.23, no.16.
@article{article, author={GÜLÇİN TEZCAN Et Al. }, title={Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed Cancer Cells}, journal={INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES}, year=2022}